Range of suitable people: CDEC talked over the uncertainty in the volume of people with reasonably critical to intense hemophilia B in Canada suitable for etranacogene dezaparvovec. Medical professionals consulted by CADTH indicated that some individuals who are classified as owning moderate or reasonable condition might have a severe bleeding phen